Abstract:While environmental exposures are not the single cause of Parkinson’s disease (PD), their interaction with genetic alterations is thought to contribute to neuronal dopaminergic degeneration. However, the mechanisms involved in dopaminergic cell death induced by gene-environment interactions remain unclear. In this work, we have revealed for the first time the role of central carbon metabolism and metabolic dysfunction in dopaminergic cell death induced by the paraquat (PQ)-α-synuclein interaction. The toxicity of PQ in dopaminergic N27 cells was significantly reduced by glucose deprivation, inhibition of hexokinase with 2-deoxy-D-glucose (2-DG), or equimolar substitution of glucose with galactose, which evidenced the contribution of glucose metabolism to PQ-induced cell death. PQ also stimulated an increase in glucose uptake, and in the levels of glucose transporter type 4 (GLUT4) and Na+-glucose transporters isoform 1 (SGLT1) proteins, but only inhibition of GLUT-like transport with STF-31 or ascorbic acid reduced PQ-induced cell death. Importantly, while autophagy protein 5 (ATG5)/unc-51 like autophagy activating kinase 1 (ULK1)-dependent autophagy protected against PQ toxicity, the inhibitory effect of glucose deprivation on cell death progression was largely independent of autophagy or mammalian target of rapamycin (mTOR) signaling. PQ selectively induced metabolomic alterations and adenosine monophosphate-activated protein kinase (AMPK) activation in the midbrain and striatum of mice chronically treated with PQ. Inhibition of AMPK signaling led to metabolic dysfunction and an enhanced sensitivity of dopaminergic cells to PQ. In addition, activation of AMPK by PQ was prevented by inhibition of the inducible nitric oxide syntase (iNOS) with 1400W, but PQ had no effect on iNOS levels. Overexpression of wild type or A53T mutant α-synuclein stimulated glucose accumulation and PQ toxicity, and this toxic synergism was reduced by inhibition of glucose metabolism/transport and the pentose phosphate pathway (6-aminonicotinamide). These results demonstrate that glucose metabolism and AMPK regulate dopaminergic cell death induced by gene (α-synuclein)-environment (PQ) interactions.

The role of quercetin on the survival of neuron-like PC12 cells and the expression of α-synuclein

Administration of quercetin improves mitochondria quality control and protects the neurons in 6-OHDA-lesioned Parkinson's disease models

Protective Effects of Querectin against MPP+-Induced Dopaminergic Neurons Injury via the Nrf2 Signaling Pathway

Protective Effects of Querectin against MPP plus -Induced Dopaminergic Neurons Injury via the Nrf2 Signaling Pathway

Quercetin Exerts a Neuroprotective Effect Through Inhibition of the Inos/no System and Pro-Inflammation Gene Expression in PC12 Cells and in Zebrafish.

Quercetin alleviates 6-OHDA-caused apoptosis in SH-SY5Y cells

Molecular mechanisms underlying protective effects of quercetin against mitochondrial dysfunction and progressive dopaminergic neurodegeneration in cell culture and MitoPark transgenic mouse models of Parkinson's Disease

Protective Effect of Compound Formula Rehmannia Against Neurotoxicity and Apoptosis Induced by Α-Syn in in Vivo and in Vitro Models of Parkinson’s Disease

Exploring the Inhibition of Quercetin on Acetylcholinesterase by Multispectroscopic and in Silico Approaches and Evaluation of Its Neuroprotective Effects on PC12 Cells

Differential Effects of Overexpression of Wild-Type and Mutant Human Α-Synuclein on MPP+-induced Neurotoxicity in PC12 Cells

Role of Autophagy and Proteasome Degradation Pathways in Apoptosis of PC12 Cells Overexpressing Human Α-Synuclein

Cell senescence induced by toxic interaction between α-synuclein and iron precedes nigral dopaminergic neuron loss in a mouse model of Parkinson's disease

Glucose Metabolism and AMPK Signaling Regulate Dopaminergic Cell Death Induced by Gene (α-Synuclein)-Environment (Paraquat) Interactions

Effect of Quercetin in the 1-Methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-Induced Mouse Model of Parkinson's Disease

Modulating SQSTM1/p62-dependent selective autophagy of neurons by activating Nrf2 with multifunctional nanoparticles to eliminate α-synuclein aggregates and boost therapy of Parkinson’s disease

Quercetin Attenuates Oxidative Stress and Apoptosis in Brain Tissue of APP/PS1 Double Transgenic AD Mice by Regulating Keap1/Nrf2/HO-1 Pathway to Improve Cognitive Impairment

Effects of quercetin in preclinical models of Parkinson's disease: A systematic review

Protective Effects of Apigenin Against 1-Methyl-4-phenylpyridinium Ion-Induced Neurotoxicity in Pc12 Cells

Dietary Intake of Α-Ketoglutarate Ameliorates Α-Synuclein Pathology in Mouse Models of Parkinson’s Disease

Quercetin ameliorates Aβ toxicity in Drosophila AD model by modulating cell cycle-related protein expression.

Curcumin reduces α-synuclein induced cytotoxicity in Parkinson's disease cell model